BXP vs OGEN · rev $3.48B vs rev $37.7K
Boston Properties Inc (BXP) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
BXP currently screens at market cap $12.12B. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the BXP and OGEN stock pages for the full models.
Not investment advice.